Pharma Mar, S.A. (BME:PHM)

Pharma Mar Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,455	1,389	738	1,158	1,033	1,313
Market Cap Growth	181.50%	88.09%	-36.23%	12.13%	-21.36%	66.27%
Enterprise Value	1,366	1,298	608	1,014	866	1,176
Last Close Price	82.80	79.80	40.37	62.30	54.82	67.91
PE Ratio	73.21	53.17	649.51	23.46	11.12	9.57
Forward PE	29.10	36.29	67.76	16.74	12.76	10.53
PS Ratio	8.28	7.94	4.67	5.90	4.49	4.87
PB Ratio	7.37	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	7.41	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	-	-	-	39.30	57.78	4.76
P/OCF Ratio	-	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	7.77	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	98.67	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	177.86	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	-76.79	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	3.75	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	-	-	-	1.45	2.76	0.21
Asset Turnover	0.53	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.21	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.23	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.97	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	10.19%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	1.44%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Capital (ROIC)	1.99%	1.63%	-0.95%	10.67%	29.89%	77.41%
Return on Capital Employed (ROCE)	3.00%	2.40%	-	14.20%	32.80%	66.60%
Earnings Yield	1.37%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	-1.22%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	0.87%	1.00%	1.61%	1.04%	1.19%	0.88%
Payout Ratio	57.46%	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	0.87%	2.98%	2.42%	1.17%	2.50%	1.65%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.